- Home
- WOLF vs RGNX Comparison
WOLF vs RGNX Comparison
Compare WOLF & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOLF | RGNX |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.2M | 418.1M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | WOLF | RGNX |
|---|---|---|
| Price | $25.57 | $8.37 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $14.33 | ★ $28.75 |
| AVG Volume (30 Days) | ★ 3.2M | 488.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,385,982,000.00 | $10,393,000.00 |
| Revenue This Year | N/A | $51.21 |
| Revenue Next Year | $7.43 | $19.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 19.00 | ★ 126.48 |
| 52 Week Low | $0.39 | $6.89 |
| 52 Week High | $36.60 | $16.19 |
Technical Indicators
Market Signals| Indicator | WOLF | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 41.10 |
| Support Level | $15.86 | $7.68 |
| Resistance Level | $34.29 | $9.41 |
| Average True Range (ATR) | 3.39 | 0.45 |
| MACD | 0.09 | -0.07 |
| Stochastic Oscillator | 35.00 | 11.18 |
Price Performance
Historical ComparisonAbout WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.